On the relevance of immunodeficiency evaluation in haematological cancer

Hematol Oncol. 2021 Dec;39(5):721-723. doi: 10.1002/hon.2921. Epub 2021 Sep 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers / analysis*
  • Evaluation Studies as Topic
  • Hematologic Neoplasms / complications*
  • Humans
  • Immunologic Deficiency Syndromes / diagnosis*
  • Immunologic Deficiency Syndromes / etiology
  • Immunologic Deficiency Syndromes / metabolism
  • Prognosis

Substances

  • Biomarkers